Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rolf Grosser is active.

Publication


Featured researches published by Rolf Grosser.


Archive | 2004

Substituted dihydrochinazolines having antiviral properties

Tobias Wunberg; Judith Baumeister; Ulrich Betz; Mario Jeske; Thomas Lampe; Susanne Nikolic; Jürgen Reefschläger; Rudolf Schohe-Loop; Frank Süssmeier; Holger Zimmermann; Rolf Grosser; Kerstin Henninger; Guy Hewlett; Jörg Keldenich; Dieter Lang; Peter Nell


Archive | 2003

An optically acitve pyridine derivative and a medicament containing the same

Toshiki Murata; Sachiko Sakakibara; Takashi Yoshino; Hiroki Sato; Yuji Koriyama; Noriko Nunami; Megumi Yamauchi; Keiko Fukushima; Rolf Grosser; Kinji Fuchikami; Kevin Bacon; Timothy B. Lowinger


Archive | 2001

Novel substituted imidazotriazinones as pde ii-inhibitors

Dagmar Schauss; Martin Hendrix; Gerhard Konig; Frank-Gerhard Böss; Der Staay Franz-Josef Van; R. Schreiber; Karl-Heinz Schlemmer; Rolf Grosser; Ulrich Niewöhner


Archive | 2004

Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents

Tobias Wunberg; Judith Baumeister; Mario Jeske; Peter Nell; Susanne Nikolic; Frank Süssmeier; Holger Zimmermann; Rolf Grosser; Kerstin Henninger; Guy Hewlett; Jörg Keldenich; Dieter Lang


Archive | 2004

Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent

Tobias Wunberg; Judith Baumeister; Mario Jeske; Peter Nell; Susanne Nikolic; Frank Süssmeier; Holger Zimmermann; Rolf Grosser; Kerstin Henninger; Guy Hewlett; Jörg Keldenich; Dieter Lang


Archive | 2007

New 1,6-naphthyridine or 8-azaquinazoline derivatives useful for treating aldosteronism, hypertension, cardiac insufficiency, myocardial infarct sequelae, liver cirrhosis, renal insufficiency and stroke

Lars Bärfacker; Rolf Grosser; Peter Kolkhof; Adam Nitsche; Karl-Heinz Schlemmer


Archive | 2008

3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Lars Bärfacker; Peter Kolkhof; Karl-Heinz Schlemmer; Rolf Grosser; Adam Nitsche


Archive | 2007

Substituierte 4-aryl-1,4-dihydro-1,6-naphthyridine und ihre verwendung

Lars Bärfacker; Peter Kolkhof; Karl-Heinz Schlemmer; Rolf Grosser; Adam Nitsche; Martina Klein; Klaus Münter; Barbara Albrecht-Küpper; Elke Hartmann


Archive | 2007

New 4-chromenonyl-1,4-dihydropyridine derivatives, useful for treatment of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor

Jens-Kerim Ergüden; Perez Santiago Figueroa; Ingo Flamme; Heike Gielen-Haertwig; Rolf Grosser; Heike Heckroth; Peter Kolkhof; Alexander Kuhl; Dieter Dr. Lang; Karl-Heinz Schlemmer


Archive | 2007

New 8-dihydropyridyl-chromene derivatives, useful for treatment and prevention of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor

Eva-Maria Becker; Jens-Kerim Ergüden; Perez Santiago Figueroa; Ingo Flamme; Heike Gielen-Haertwig; Rolf Grosser; Heike Heckroth; Peter Kolkhof; Alexander Kuhl; Karl-Heinz Schlemmer

Collaboration


Dive into the Rolf Grosser's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge